Combination therapy in childhood leukaemia: In vitro studies of thiopurines and inhibitors of purine metabolism on apoptosis

Annals of Clinical Biochemistry

Volumn 40, Issue 1, 2003, Pages 70-74

  De Abreu, Ronney A ^a   Trueworthy, Robert C ^b   Van Kuilenburg, André B P ^c   Vogels Mentink, Trude M ^a   Lambooy, Lambert H J ^a   Van Gennip, Albert H ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; METHOTREXATE; TIAZOFURIN; TIOGUANINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PURINE METABOLISM;

6-MERCAPTOPURINE; ANNEXIN A5; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL SURVIVAL; CHILD; COLORING AGENTS; HUMANS; LEUKEMIA; METHOTREXATE; MODELS, BIOLOGICAL; PURINES; RIBAVIRIN; THIOGUANINE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 12244278249     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456303321016196     Document Type: Article

References (15)

1. Vitali M, Zamai L, Falcieri E, Zauli G, Gobbi P, Santi S, et al. IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis on K562 human erythroleukemia cells. Cytometry 1997; 30: 61-6
2. Simonian PL, Grillot DAM, Nunez G. Bcl-2 and Bcl-XI can differentially block chemotherapy-induced cell death. Blood 1997; 90: 1208-16
3. Martin DS, Schwartz GK. Chemotherapeutically induced DNA damage, ATP depletion, and apoptotic biochemical cascade. Oncol Res 1997; 9: 1-5
4. Olah E, Csokay B, Prajda N, Kote-Jarai Z, Yeh YA, Weber G. Molecular mechanisms in the antiproliferative action of taxol and tiazofurin. Anticancer Res 1996; 16: 2469-78
5. Genestier L, Paillot R, Fournel S, Ferraro C, Miossec P, Revillard J. Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest 1998; 102: 322-8
6. Hortelano S, Boscá L. 6-Mercaptopurine decreases the Bcl-2/Bax ratio and induces apoptosis in activated splenic B lymphocytes. Mol Pharmacol 1997; 51: 414-21
7. Posovszky C, Friesen C, Herr I, Debatin KM Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosis. Leukemia 1999; 13: 400-9
8. El-Alaoui S, Lawry J, Griffin M. The cell cycle and induction of apoptosis in a hamster fibrosarcoma cell line treated with anticancer drugs: Its importance to solid tumour chemotherapy. J Neurooncol 1997; 31: 195-207
9. daSilva CP, deOliveira CR, DaConceicao M, deLima P. Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes. Biochem Pharmacol 1996; 51: 1331-40
10. Tsurusawa M, Sacki K, Fujimoto T. Differential induction of apoptosis on human lymphoblastic leukaemia Nalm-6 and Molt-4 cells by various antitumor drugs. Int J Hematol 1997; 66: 79-88
11. Morgon CJ, Chawdry RN, Smith AR, Siravo-Sagraves G, Trewyn RW. 6-Thioguanine-induced growth arrest in 6-mercaptopurine-resistant human leukaemia cells. Cancer Res 1994; 54: 5387-93
12. Frei E, Acute Leukemia Group B. Studies of sequential and combination antimetabolite therapy in acute leukemia: 6-mercaptopurine and methotrexate. Blood 1961; 18: 965-79
13. Visani G, Tosi P, Zinzani PL, Manfroi S, Zaccaria A, Testoni N, et al. FLAG (fludarabine+cytosine arabinoside+G-CSF) induces complete remission in acute-phase chronic myeloid leukemia: A case report. Br J Haematol 1994; 86: 394-6
14. VanEngeland N, Nieland LJW, Ramaekers FCS, Schutte B, Reutelingsperger CPM. Annexin V affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998; 31: 1-9
15. Reutelingsperger CPM, van Heerde WL. Annexin V, the regulator of phosphatidylserine-catalysed inflammation and coagulation during apoptosis. Cell Mol Life Sci 1997; 53: 527-32